Electrotherapy in the Management of Myofascial Syndrome (MODYMYO)
Primary Purpose
Breast Cancer
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
TENS (transcutaneous electrical nerve stimulation)
TENS (transcutaneous electrical nerve stimulation) ECOMODYN
Sponsored by

About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring Breast cancer, Surgery, Myofascial syndrome
Eligibility Criteria
Inclusion Criteria:
- Male or female who had first breast cancer surgery, regardless of the type of surgery
- Age ≥ 18 years
- Patients with refractory pain with myofascial syndrome, with a numerical scale ≥ 4
- Topical treatment for refractory pain completed more than 30 days ago
- Healthy, non-irritated skin on painful areas to treat
- Patient with a third party who can attend visits M0 and M2.5
- Obtaining the signed written consent of the patient
- Major patient affiliated to a social security scheme
Exclusion Criteria:
- Patient who has used TENS before on the muscles affected by the myofascial syndrome
- Post-surgery management of the affected area by a physiotherapist
- Person with venous thrombosis
- Contraindications specific to the treatments studied
Sites / Locations
- Institut de Cancerologie de l'Ouest
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
TENS / TENS ECOMODYN
TENS ECOMODYN / TENS
Arm Description
Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS / TENS ECOMODYN Patients first start with TENS during 2 months puis change with TENS ECOMODYN during 2 months with a wash-out period of 15 days
Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS ECOMODYN / TENS Patients first start with TENS ECOMODYN during 2 months puis change with TENS during 2 months with a wash-out period of 15 days
Outcomes
Primary Outcome Measures
The main objective is to evaluate the effectiveness of TENS and TENS ECOMODYN® on the management of chronic breast pain after surgery.
Chronic pain is assessed using the Digital Pain Rating Scale (0 worse outcome to 10 better outcome) before and after using the method (TENS and TENS ECOMODYN®) at M0, M2, M2.5 and M4.5.
Secondary Outcome Measures
Evaluate the changes made by the treatment felt by the patient
The intensity of The patient's feelings will be evaluated by the Patient Global Impression of Change questionnaire: at M2 and M4.5
Full Information
NCT ID
NCT04936451
First Posted
June 15, 2021
Last Updated
July 31, 2023
Sponsor
Institut Cancerologie de l'Ouest
1. Study Identification
Unique Protocol Identification Number
NCT04936451
Brief Title
Electrotherapy in the Management of Myofascial Syndrome
Acronym
MODYMYO
Official Title
Contribution of an Electrotherapy Technique Such as TENS ECOMODYN® vs Electrotherapy Only Type TENS in the Management of Myofascial Syndrome After Breast Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Terminated
Why Stopped
lack of recrutment
Study Start Date
January 5, 2022 (Actual)
Primary Completion Date
April 14, 2023 (Actual)
Study Completion Date
April 14, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Cancerologie de l'Ouest
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Myofascial syndrome is defined as "musculoskeletal pain characterized by local and referred pain perceived to be deep and constant, and by the presence of myofascial trigger points in any part of the body" Post-breast surgery myofascial syndrome affects up to 44.7% of operated women, mainly on the muscles of the greater shoulder girdle. The repercussions are significant, functional, somatic, psychological and socio-professional affecting the quality of life. The treatments offered may or may not be medicinal. Transcutaneous electrical nerve stimulation (TENS) is a therapy that uses low voltage electrical current to provide pain relief. A TENS unit consists of a battery-powered device that delivers electrical impulses through electrodes placed on the surface of your skin. The electrodes are placed at or near nerves where the pain is located or at trigger points.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Breast cancer, Surgery, Myofascial syndrome
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Monocentric, randomized in cross over in two arms, open
Masking
None (Open Label)
Allocation
Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TENS / TENS ECOMODYN
Arm Type
Other
Arm Description
Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS / TENS ECOMODYN Patients first start with TENS during 2 months puis change with TENS ECOMODYN during 2 months with a wash-out period of 15 days
Arm Title
TENS ECOMODYN / TENS
Arm Type
Other
Arm Description
Patients who have signed their consent receive, after randomization, the trial treatments assigned to them. Arm TENS ECOMODYN / TENS Patients first start with TENS ECOMODYN during 2 months puis change with TENS during 2 months with a wash-out period of 15 days
Intervention Type
Device
Intervention Name(s)
TENS (transcutaneous electrical nerve stimulation)
Intervention Description
Patients will benefit from screening for refractory pain, neuropathic or not, with myofascial syndrome, between 3 and 12 months after surgery.
The healthcare professional will determine 4 trigger points. TENS is applied twice 45 min every day for 2 months. Pain treatment will be done by using the P6 program in alternative mode: 2hz / 100Hz.
The time between 2 electrostimulations will be a minimum of 4 hours and a maximum of 15 hours.
Intervention Type
Device
Intervention Name(s)
TENS (transcutaneous electrical nerve stimulation) ECOMODYN
Intervention Description
TENS ECOMODYN® is applied to 4 treatment points, 5 minutes per point 2 times a day for 2 months.
A minimum rest period of 4 hours between 2 sessions on the same point must be respected Stimulation is performed directly with the bipolar probe of the TENS ECOMODYN® device on the painful area by fixed stimulation of 4 active pain points in 77Hz mode.
Primary Outcome Measure Information:
Title
The main objective is to evaluate the effectiveness of TENS and TENS ECOMODYN® on the management of chronic breast pain after surgery.
Description
Chronic pain is assessed using the Digital Pain Rating Scale (0 worse outcome to 10 better outcome) before and after using the method (TENS and TENS ECOMODYN®) at M0, M2, M2.5 and M4.5.
Time Frame
16,5 months
Secondary Outcome Measure Information:
Title
Evaluate the changes made by the treatment felt by the patient
Description
The intensity of The patient's feelings will be evaluated by the Patient Global Impression of Change questionnaire: at M2 and M4.5
Time Frame
16.5 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female who had first breast cancer surgery, regardless of the type of surgery
Age ≥ 18 years
Patients with refractory pain with myofascial syndrome, with a numerical scale ≥ 4
Topical treatment for refractory pain completed more than 30 days ago
Healthy, non-irritated skin on painful areas to treat
Patient with a third party who can attend visits M0 and M2.5
Obtaining the signed written consent of the patient
Major patient affiliated to a social security scheme
Exclusion Criteria:
Patient who has used TENS before on the muscles affected by the myofascial syndrome
Post-surgery management of the affected area by a physiotherapist
Person with venous thrombosis
Contraindications specific to the treatments studied
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
EVA KERROUAULT, MD
Organizational Affiliation
Institut de Cancérologie de l'Ouest
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut de Cancerologie de l'Ouest
City
Saint-Herblain
ZIP/Postal Code
44805
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Electrotherapy in the Management of Myofascial Syndrome
We'll reach out to this number within 24 hrs